Journal
PROTEOMICS CLINICAL APPLICATIONS
Volume 3, Issue 10, Pages 1140-1150Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/prca.200780035
Keywords
Cancer; Drug discovery; Quantitative biology; Reverse-phase protein array; Systems biology
Funding
- National Genome Research Net (NGFN)
- German Federal Ministry for Education and Research (BMBF) [PTJ-Bio/0313336]
- [01GR0418]
Ask authors/readers for more resources
A detailed and quantitative analysis of disease-relevant signaling will greatly contribute to our understanding of tumorigenesis and cancer progression, and thus open new strategies for drug discovery. However, throughput and sensitivity of currently established methods available for proteome profiling do not comply with the needs of clinical research such as high sample capacity and low sample consumption. Protein microarrays emerged as a promising alternative to analyze the abundance of proteins and their phosphorylation status on a high-throughput level. Here we summarize recent methodological advancements in the field of reverse-phase protein arrays and demonstrate their potential for clinical research as well as for in vitro applications.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available